The abstract is read at the publisher; the summary is JClub's.
In a single Undiagnosed Diseases Network clinical site, 77 of 192 participants (40%) with prior nondiagnostic exome/genome sequencing achieved 80 diagnoses, with research reanalysis yielding 54%.
- Why it matters: Most people remain undiagnosed after clinical exome sequencing, and incremental diagnosis from reanalysis or genome sequencing is limited, creating a need for better pathways to resolve nondiagnostic results.
- What they did: This retrospective review compared diagnostic routes after nondiagnostic NGS—Undiagnosed Diseases Network research reanalysis, clinical ES/GS, other genetic testing, and clinical diagnosis—then characterized variant types and why findings were missed.
- The result: Research reanalysis of raw data produced the most diagnoses (54%), and 72% of genetic diagnoses should have been detectable from prior ES, often because novel gene variants (53%) or known-gene variants with perceived phenotypic mismatch (17%) were not prioritized.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.